TY - JOUR AU - Yamamoto, Norio AU - Watanabe, Tetsuya AU - Yamada, Kazuhiro AU - Nakai, Toshiyuki AU - Suzumura, Tomohiro AU - Sakagami, Kazuki AU - Yoshimoto, Naoki AU - Sato, Kanako AU - Tanaka, Hidenori AU - Mitsuoka, Shigeki AU - Asai, Kazuhisa AU - Kimura, Tatsuo AU - Kanazawa, Hiroshi AU - Hirata, Kazuto AU - Kawaguchi, Tomoya PY - 2019 TI - Efficacy and safety of ultrasound (US) guided percutaneous needle biopsy for peripheral lung or pleural lesion: comparison with computed tomography (CT) guided needle biopsy JF - Journal of Thoracic Disease; Vol 11, No 3 (March 29, 2019): Journal of Thoracic Disease Y2 - 2019 KW - N2 - Background: Ultrasound (US)-guided percutaneous needle biopsy is a useful diagnostic technique with short examination time and real-time monitoring at the bedside. However, there are only a few studies that report on thoracic lesions, whereas the computed tomography (CT)-guided biopsy is well established. There is also limited data comparing US- and CT-guided biopsy. We aimed to clarify the efficacy and safety of US-guided biopsy for thoracic lesions adjacent to the chest wall. Methods: We retrospectively enrolled consecutive patients who underwent US- or CT-guided percutaneous biopsies for thoracic lesions adjacent to the chest wall between April 2012 and December 2017. Clinical characteristics, lesion size, lesion-pleura contact arc length (LPCAL), diagnostic rate, and complications were compared between the 2 groups. Results: This study enrolled 61 US-guided and 70 CT-guided biopsies. No significant difference was found in age or sex. The lesion size and LPCAL in the US-guided group were significantly larger than those in the CT-guided group (P 40 mm was significantly higher in the US-guided group than in the CT-guided group (P=0.009). Complication rates were significantly lower in the US-guided group (3.3%) than in the CT-guided group (24.3%) (P Conclusions: US-guided percutaneous needle biopsy for thoracic lesions adjacent to the chest wall is a feasible technique compared with CT-guided biopsy because of its higher diagnostic rate with a longer LPCAL and reduced complications. UR - https://jtd.amegroups.org/article/view/27034